OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.
Oxford Cannabinoid Technologies has raised $714K in total funding. The most recent round was Post-IPO Debt. The last funding was announced in February 2024.
Oxford Cannabinoid Technologies's investors include Casa Verde Capital, Julien Codorniou, Kingsley Capital Partners, Neil Mahapatra, Cantheon Capital.
Oxford Cannabinoid Technologies is headquartered in Oxford, United Kingdom.
OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.
Oxford Cannabinoid Technologies is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oxford Cannabinoid Technologies — Funding & Investors." VCBacked, February 2, 2024, https://www.vcbacked.co/company/oxford-cannabinoid-technologies. Accessed August 14, 2026.
VCBacked. (2024). Oxford Cannabinoid Technologies — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/oxford-cannabinoid-technologies
{{cite web |title=Oxford Cannabinoid Technologies — Funding & Investors |url=https://www.vcbacked.co/company/oxford-cannabinoid-technologies |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated